| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701969 | Journal of Thoracic Oncology | 2017 | 18 Pages |
Abstract
Improved survival is associated with receipt of PORT for patients with pathologic stage IIIA (N2) NSCLCÂ treated with complete resection and multiagent chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alex MD, Elizabeth MS, Paul PhD, Himanshu MD,